Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2010
10/28/2010US20100272753 Recombinant Adenovirus Vaccines
10/28/2010US20100272749 Optimized expression of HPV 58 L1 in yeast
10/28/2010US20100272747 Polyvalent chimeric rubella virus-based vaccines
10/28/2010US20100272746 Lipoparticle comprising a protein and methods of making and using the same
10/28/2010US20100272691 Viruses
10/28/2010US20100272686 Oncolytic virus
10/28/2010US20100272685 Porcine Adeno-Associated Viruses
10/27/2010EP2243827A1 Serum-free mammalian cell culture medium, and uses thereof
10/27/2010EP2242840A1 Recombinant virus production using mammalian cells in suspension
10/27/2010EP1649011B1 Culture method for keratinocytes and use thereof
10/27/2010EP1119627B1 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons
10/27/2010EP0979101B1 Recombinant canine adenovirus 2 (cav2) containing exogenous dna
10/27/2010CN1384877B Rescue of mumps virus from cDNA
10/27/2010CN101870963A Recombinant Newcastle disease virus attenuated vaccine strain for expressing dog interferon (alpha, beta or gamma)
10/27/2010CN101869702A Vaccine produced by suspended microcarrier cell culture system and method for producing vaccine
10/27/2010CN101249261B Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same
10/26/2010US7820671 Peptidomimetic protease inhibitors
10/26/2010US7820441 Production of viral vectors
10/26/2010US7820436 Genetic engineered herpes virus genomes; vaccine; gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus
10/26/2010US7820426 Bionanomaterials and their synthesis
10/26/2010US7820182 Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
10/26/2010US7820181 Generating expression vectors comprising myxoviral gene sequences for use as tool in developing vaccines to prevent infection and respiratory sysytem disorders; genetic vaccines and viral diseases
10/26/2010US7820157 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine
10/26/2010CA2271438C Method for producing recombinant virus
10/21/2010WO2010120266A1 Hpv particles and uses thereof
10/21/2010US20100267121 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
10/21/2010US20100267117 Bacteriophage Having Killing Activity Specific to Staphylococcus Aureus
10/21/2010US20100267116 Filovirus vectors and noninfectious filovirus-based particles
10/21/2010US20100266633 Aids virus vaccines using sendai virus vector
10/21/2010US20100266631 Compositions and Methods for Generating an Immune Response Utilizing Alphavirus-Based Vector Systems
10/21/2010US20100266630 Recombinant MVA virus, and the use thereof
10/21/2010US20100266585 Monoclonal Antibodies Specific to Hemagglutinin and Neuraminidase from Influenza Virus H5-Subtype or N1-Subtype and Uses Thereof
10/21/2010US20100266546 Selectively replicating viral vectors
10/21/2010DE19953021B4 Verfahren und Einrichtung zum Erzeugen eines Mehrfarbendruckes Method and apparatus for generating a multi-color print
10/21/2010CA2795906A1 Hpv particles and uses thereof
10/20/2010EP2241623A2 Monoclonal antibody against a human cytokine receptor
10/20/2010EP1877549B1 Hiv vaccine
10/20/2010EP1060241B2 Preparation of cells for production of biologicals
10/20/2010EP0710280B1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
10/20/2010CN101864400A Specific recombinant adenoviruses, preparation thereof and use thereof
10/20/2010CN101864399A Enterovirus and application thereof
10/19/2010US7816130 Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences
10/19/2010US7816104 Packaging cells for recombinant adenovirus
10/19/2010US7816073 by the addition of 1 mM-10 mM L-carnitine and derivatives extended circulation half life upon transfusion to a patient; permits irradiation of sealed containers of blood products so as to substantially sterilize and destroy leukocytes in the same
10/19/2010US7815915 Mixture of human papillomavirus virus-like particles
10/19/2010US7815902 Methods and compositions for cancer therapy using a novel adenovirus
10/19/2010CA2479747C Cotton rat lung cells for virus culture
10/19/2010CA2430661C Purified active hcv ns2/3 protease
10/19/2010CA2400667C Modified nodavirus rna for gene delivery
10/19/2010CA2337618C Chicken anaemia viruses of low pathogenicity
10/14/2010WO2010116096A1 Method for purifying the rabies virus
10/14/2010WO2010115735A2 Methods for inactivating viruses
10/14/2010WO2010074433A3 Novel bacteriophage and antibacterial composition comprising same
10/14/2010US20100261875 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/14/2010US20100261254 Baculoviral vectors comprising repeated coding sequences with differential codon biases
10/14/2010US20100260807 Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens
10/14/2010US20100260799 SIMIAN SUBFAMILY C ADENOVIRUSES SAdV-40, -31, AND -34 AND USES THEREOF
10/14/2010US20100260798 Method for purifying the rabies virus
10/14/2010US20100260713 Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs
10/14/2010US20100260710 Macrocyclic serine protease inhibitors
10/14/2010US20100260673 Phage display peptide probes for imaging early responses to antiangiogenic treatment
10/14/2010US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof
10/14/2010CA2757895A1 Method for purifying the rabies virus
10/13/2010EP2239325A1 Virus growing in hypoxic cell or virus vector expressing gene therein
10/13/2010EP2239321A1 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus
10/13/2010EP2238253A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
10/13/2010EP1694852B1 Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer
10/13/2010CN101861387A Novel bacteriophage and antibacterial composition containing the same
10/13/2010CN101857873A Hemangioma pathotype subgroup J avian leukosis virus gene and construction of infectious clone thereof
10/13/2010CN101857872A Replacement method of influenza A Virus antigenic determinant
10/13/2010CN101856501A Tumor targeted molecular chemotherapeutic gene-virus preparation SG500-deoxyribonucleoside kinase of drosophila melanogaster (SG500-Dm-dNK) and building method and application thereof
10/13/2010CN101280292B Virus velogen strain for porcine reproductive and respiratory syndrome, attenuated vaccine strain thereof and application thereof
10/12/2010US7811812 For use in gene therapy and recombinant protein production
10/12/2010US7811588 Therapeutic agent for treatment and prevention of bacterial infections; immunoassay
10/12/2010US7811582 Herpes viruses for immune modulation
10/12/2010US7811579 Full-length genomic RNA of Japanese encephalitis virus, infectious JEV cDNA therefrom, and use thereof
10/12/2010CA2339034C Process for purifying human papillomavirus virus-like particles
10/12/2010CA2327528C Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
10/12/2010CA2196570C Recombinant herpesvirus of turkeys and uses thereof
10/07/2010WO2010113647A1 Vector utilizing borna disease virus and use thereof
10/07/2010WO2010112935A1 Diagnostic test for virus
10/07/2010WO2010112533A1 Enhanced production of papillomavirus-like particles with a modified baculovirus expression system
10/07/2010WO2010077986A3 Production of influenza vaccines
10/07/2010WO2009105084A8 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof
10/07/2010WO2008140414A8 Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection
10/07/2010US20100255559 Apparatus and process for treating an aqueous solution containing biological contaminants
10/07/2010US20100255524 Method for stabilising a biological sample
10/07/2010US20100255038 Purified polypeptide comprising or consisting of a c-terminus msp1 antigen from plasmodium falciparum carrying a glycosyl-phosphatidyl-inositol group (gpi)
10/07/2010US20100255030 Avirulent, immunogenic flavivirus chimeras
10/07/2010US20100255028 Flavivirus Vaccine Vector Against Influenza Virus
10/07/2010US20100255027 Papilloma pseudovirus and preparation
10/07/2010US20100254947 SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF
10/06/2010EP2235163A1 Recombinant bcg tuberculosis vaccine for eliciting immune responses to mycobacterium tuberculosis
10/06/2010CN1646684B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
10/06/2010CN1616665B Targeted liposome gene delivery
10/06/2010CN101852807A Sorghum mosaic virus tri-anti sandwich enzyme-linked immuno sorbent assay kit
10/06/2010CN101851636A Recombinant influenza viruses for vaccines and gene therapy
10/06/2010CN101851610A Method for producing rabies virus antigens for animals at a large scale
10/06/2010CN101851609A Porcine parvovirus L strain and use thereof in preparation of porcine parvovirus inactivated vaccines
10/06/2010CN101851608A Method for producing rabies viruses by suspension culture of BHK21 cells
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 267